ArticleInternational journal of hematology2016
Safety and tolerability of ibrutinib monotherapy in Japanese patients with relapsed/refractory B cell malignancies.
Kensei Tobinai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it